SCHEMBL30201723

SCHEMBL30201723

CC(C)(C)OC(=O)N1CCC(Oc2ccc(-c3ccc(OCc4ccccc4)nc3OCc3ccccc3)cn2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 10/20 0.51
PRMT5 O14744 5/20 0.49
CACNB4 O00305 2/20 0.45
CACNA1A O00555 2/20 0.45
CACNA1G O43497 2/20 0.45
CACNG3 O60359 2/20 0.45
CACNA1F O60840 2/20 0.45
CACNA1H O95180 2/20 0.45
CACNB3 P54284 2/20 0.45
CACNA2D1 P54289 2/20 0.45
CACNG7 P62955 2/20 0.45
CACNA1B Q00975 2/20 0.45
CACNA1D Q01668 2/20 0.45
CACNB1 Q02641 2/20 0.45
CACNG1 Q06432 2/20 0.45
CACNB2 Q08289 2/20 0.45
CACNA1S Q13698 2/20 0.45
CACNA1C Q13936 2/20 0.45
CACNA1E Q15878 2/20 0.45
CACNA2D4 Q7Z3S7 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25074065 1.00 GPR119 (0.51) GPR119PRMT5CACNB4CACNA1ACACNA1G
SCHEMBL29223506 0.91 PRMT5 (0.53) GPR119PRMT5CACNB4CACNA1ACACNA1G
SCHEMBL30830568 0.87 PRMT5 (0.47) GPR119PRMT5CACNB4CACNA1ACACNA1G
SCHEMBL30831113 0.87 GPR119 (0.48) GPR119PRMT5CACNB4CACNA1ACACNA1G
SCHEMBL24206930 0.86 PRMT5 (0.52) GPR119PRMT5PIK3CDHPGDSYAP1
SCHEMBL25188954 0.86 DDB1 (0.43) GPR119PRMT5CACNB4CACNA1ACACNA1G
SCHEMBL10196271 0.84 PRMT5 (0.52) GPR119PRMT5CACNB4CACNA1ACACNA1G
SCHEMBL25199235 0.84 GPR119 (0.53) GPR119PRMT5
SCHEMBL30888790 0.84 GPR119 (0.53) GPR119PRMT5
SCHEMBL31382255 0.84 PRMT5 (0.53) GPR119PRMT5YAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4367118-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF Nurix Therapeutics, Inc. (US) 2024-05-15 EP disclosed
WO-2023023255-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF NURIX THERAPEUTICS, INC. (US) 2023-02-23 WO disclosed